Countries China
CellOrigin Treats First CAR-M Patient in China, Unveils Second-Gen CAR-M for Solid Tumors
"A single center, single-arm, dose-escalation, exploratory clinical trial to examine the safety, tolerability, pharmacokinetics and prelimina...
December 21, 2023 | News
InxMed Licenses Next-Gen ADCs with Escugen
The license agreement provides InxMed with right to use EZWi-Fit® platform on the several novel ADC candidate molecules. InxMed will hav...
December 20, 2023 | News
NMPA Accepts Mabwell's 8MW0511 Injection New Drug Application
8MW0511, a Class 1 therapeutic biological product, is a new generation of long-acting G-CSF (modified cytokine with high activity) with independent intelle...
December 20, 2023 | News
InnoCare's TYK2 Inhibitor ICP-332 Meets Phase II Endpoint in Atomic Dermatitis Study
ICP-332 in AD patients treated for 4 weeks demonstrated excellent efficacy and safety profile. ICP-332 achieved multiple efficacy endpoints including Eczem...
December 18, 2023 | News
GeneQuantum and BioMap Collaborate on Next-Gen ADC Therapeutics
The partnership will combine GQ's proprietary enzymatic site-specific conjugation technology platforms (iLDC® and iGDC®), linker-payload platform, ...
December 18, 2023 | News
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate
Clover Biopharmaceuticals, Ltd. a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save li...
December 13, 2023 | News
Zhongchao Inc. Partners with Public Health Foundation for Cancer Treatment Advancements
The Project offers free Doxorubicin Hydrochloride Liposome Injections to low-income patients with breast cancer, lymphoma, Kaposi's sarcoma, ovarian cancer...
December 12, 2023 | News
CStone's Sugemalimab Granted NMPA Approval for Esophageal Cancer
Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy...
December 11, 2023 | News
CRISPR Explores Future of Cell & Gene Therapy at 2024 GenScript Biotech Global Forum
Recently, the world's first CRISPR/Cas9 gene editing therapy received market approval in the UK. This significant achievement comes 11 years after the inve...
December 08, 2023 | News
WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader
The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...
December 07, 2023 | News
Innovent Biologics and Synaffix Expand ADC Collaboration Amid Promising Phase 1 Results
The expanded deal builds on a previous agreement signed in June 2021, under which Innovent is granted to deploy Synaffix's ADC technologies on a targe...
December 07, 2023 | News
FDA Clears CARsgen's CT071 for Relapsed/Refractory Multiple Myeloma
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...
December 05, 2023 | News
China Pharma Completes Third-Party Testing for Dry Eye Therapeutic Device
According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 34...
November 30, 2023 | News
Merck Expands Newest Biologics Testing Center in Shanghai
Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...
November 30, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
